These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35611731)

  • 61. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
    Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of the immune response elicited by vaccination with viral vectors encoding FMDV capsid proteins and boosted with inactivated virus.
    Romanutti C; D'Antuono A; Palacios C; Quattrocchi V; Zamorano P; La Torre J; Mattion N
    Vet Microbiol; 2013 Aug; 165(3-4):333-40. PubMed ID: 23683999
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Construction and characterization of recombinant human adenovirus type 5 expressing foot-and-mouth disease virus capsid proteins of Indian vaccine strain, O/IND/R2/75.
    Kumar R; Sreenivasa BP; Tamilselvan RP
    Vet World; 2015 Feb; 8(2):147-55. PubMed ID: 27047064
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Construction and identification of recombinant adenovirus containing the polyproteins coding regions of O type foot-and-mouth disease virus by homologous recombination in Escherichia coli].
    Zhang XW; Wang Q; Liu JX; Yin XP; Li ZY
    Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):223-6. PubMed ID: 16736581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
    Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z
    J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunogenicity analysis of the E. coli expressed structural protein VP1 of persistent infection foot-and-mouth disease virus.
    Tang H; Wang H; Yang L; Chen H; Kong L; Xin X
    Virology; 2023 Feb; 579():111-118. PubMed ID: 36634474
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination].
    Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
    Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
    Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Design and immunogenicity evaluation for the bacteria-like particle vaccine against swine type O foot-and-mouth disease virus].
    Hou L; Chen J; Qiao X; Yu X; Hou J; Zheng Q; Li J
    Sheng Wu Gong Cheng Xue Bao; 2017 Feb; 33(2):217-227. PubMed ID: 28956378
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase.
    Cedillo-Barrón L; Foster-Cuevas M; Belsham GJ; Lefèvre F; Parkhouse RME
    J Gen Virol; 2001 Jul; 82(Pt 7):1713-1724. PubMed ID: 11413383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs.
    Cao Y; Lu Z; Sun J; Bai X; Sun P; Bao H; Chen Y; Guo J; Li D; Liu X; Liu Z
    Vet Microbiol; 2009 May; 137(1-2):10-7. PubMed ID: 19167843
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs.
    Rao JP; Agrawal P; Mohammad R; Rao SK; Reddy GR; Dechamma HJ; S Suryanarayana VV
    Acta Virol; 2012; 56(2):91-9. PubMed ID: 22720698
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Construction and immune response characterization of a recombinant pseudorabies virus co-expressing capsid precursor protein (P1) and a multiepitope peptide of foot-and-mouth disease virus in swine.
    He Y; Qian P; Zhang K; Yao Q; Wang D; Xu Z; Wu B; Jin M; Xiao S; Chen H
    Virus Genes; 2008 Apr; 36(2):393-400. PubMed ID: 18246420
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris.
    Balamurugan V; Renji R; Saha SN; Reddy GR; Gopalakrishna S; Suryanarayana VV
    Virus Res; 2003 Apr; 92(2):141-9. PubMed ID: 12686422
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Virus-like particles of recombinant PCV2b carrying FMDV-VP1 epitopes induce both anti-PCV and anti-FMDV antibody responses.
    Li X; Meng X; Wang S; Li Z; Yang L; Tu L; Diao W; Yu C; Yu Y; Yan C; Wang L
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10541-10550. PubMed ID: 30338355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.